Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1

Sponsor Class

OTHER 7 INDUSTRY 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 54 Cisplatin 48 Paclitaxel 47 Carboplatin 43 Gemcitabine 38 pembrolizumab 36 Docetaxel 35 Capecitabine 35 Drug Therapy 34 anlotinib 25 Bevacizumab 25 Cyclophosphamide 24 icotinib 23 Fluorouracil 23 fludarabine 19 Oxaliplatin 19 Pemetrexed 17 Leucovorin 16 Irinotecan 15 Temozolomide 14 Nivolumab 14 Doxorubicin 14 Cetuximab 14 camrelizumab 13 apatinib 13 Trastuzumab 12 Rituximab 11 Fulvestrant 11 Etoposide 11 tesetaxel 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × INDUSTRY × Biopsy, Large-Core Needle × Clear all

NCT04500262 2023-06-01

COMPULSE

NeoDynamics AB

Phase NA Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡